ArticleActa pharmaceutica Sinica. B2020

Discovery of the anti-angiogenesis effect of eltrombopag in breast cancer through targeting of HuR protein.

Yuying Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.